II

Isaam Irfan Jambharkar

Active Director Director DIN 10337407
DIN 10337407 First appointment Sep 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Isaam Irfan Jambharkar

Data last updated:

Isaam Irfan Jambharkar is a Director at Isamo Pharmaceuticals Private Limited (since 2023). The company operates in Pharma.

DIN 10337407
Primary Designation Director
Industry Pharma
First Appointment 27 Sep 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Sep 20232023Active

Board colleagues of Isaam Irfan Jambharkar

Directorship timeline

Open interactive timeline →
Isamo Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Isaam Irfan Jambharkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Isaam Irfan Jambharkar

Isaam Irfan Jambharkar currently holds 1 directorship: Isamo Pharmaceuticals Private Limited (Director, since 27 Sep 2023).

Isaam Irfan Jambharkar was first appointed on 27 Sep 2023 as Director at Isamo Pharmaceuticals Private Limited.

The current boards of Isaam Irfan Jambharkar's companies include Ajay Kash Maddimadugu (Isamo Pharmaceuticals Private Limited), Monika Ongole (Isamo Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available